Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1996
12/03/1996US5580985 Substituted pyrazoles for the treatment of inflammation
12/03/1996US5580982 Antidepressants; anticholinergic agents; alzheimer's disease; amine oxidase inhibitors
12/03/1996US5580901 Percutaneous anesthetics
12/03/1996US5580900 Macrocyclic compounds
12/03/1996US5580895 1,5-benzodiazepine derivatives
12/03/1996US5580892 Antidiarrhetic, antispastic, antiepileptic agents; diuretics
12/03/1996US5580891 Antipsychotic agents, analgesics
12/03/1996US5580890 Psychological disorders
12/03/1996US5580887 1- (arylthioalkyl , arylaminoalkyl or arylmethylenealkyl) -4- (heteroaryl) piperidines and related compounds useful as anti-psychotics and analgesics
12/03/1996US5580886 Cis-2-[(4-heteroaryl-1-piperidinyl)alkyl]hexahydro-1H-isoindole-1,3(2H)-diones and related compounds and their therapeutic utility
12/03/1996US5580885 5-HT4 receptor antagonists
12/03/1996US5580882 Use of substituted quinoline carboxamide
12/03/1996US5580879 N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]-1H-benz[DE]isoquinoline-1;3(2H)-diones and related compounds and their therapeutic utility
12/03/1996US5580878 Treating sleep disorders
12/03/1996US5580875 Antipsychotic and analgesic agents
12/03/1996US5580866 Therapeutic 1,4-thiazepines
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
12/03/1996US5580580 3-aminopyridine or 3,4-diaminopyridine; useful for multiple sclerosis and alzheimer's disease
12/03/1996US5580555 Administering tumor necrosis factor and irradiating with low energy laser
12/03/1996CA2176766A1 Indanylpiperidines as melatonergic agents
12/03/1996CA2175395A1 Melatonergic indanyl piperazines or homopiperazines
12/03/1996CA2075833C Neuropeptide control of ocular growth
11/1996
11/28/1996WO1996037775A1 Methods for g protein coupled receptor activity screening
11/28/1996WO1996037500A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
11/28/1996WO1996037498A1 5H-THIAZOLO[3,2-a]PYRIMIDIN-5-ONE DERIVATIVES
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037488A1 Piperazine derivatives
11/28/1996WO1996037487A1 Process for producing thiazolidine derivatives
11/28/1996WO1996037456A1 New catechol derivatives
11/28/1996WO1996037226A2 Combinations for the treatment of parkinsonism containing selective nmda antagonists
11/28/1996WO1996037216A1 Method of administration of igf-i
11/28/1996WO1996037200A1 Use of dha as a pharmaceutical composition
11/28/1996WO1996037199A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
11/28/1996WO1996037197A1 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase
11/28/1996WO1996025931A3 Use of fused benzothiazoles as neuroprotectants
11/28/1996DE19519979A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2221695A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
11/28/1996CA2221458A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
11/28/1996CA2218726A1 Methods for g protein coupled receptor activity screening
11/28/1996CA2218018A1 Method of administration of igf-i
11/28/1996CA2195979A1 Use of dha as a pharmaceutical composition
11/28/1996CA2195578A1 5h-thiazolo[3,2-a]pyrimidin-5-one derivatives
11/27/1996EP0743946A1 5ht2b receptor antagonists condensed indoles
11/27/1996EP0743945A1 Heterocyclic compounds and their preparation and use
11/27/1996EP0743944A1 Azacyclic derivatives
11/27/1996EP0743942A1 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists
11/27/1996EP0743940A1 New compounds with analgesic and local anaesthetic effect
11/27/1996EP0743939A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
11/27/1996EP0743936A1 Cyclohexane derivatives as voltage-gated potassium channel blockers
11/27/1996EP0743858A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
11/27/1996EP0743855A1 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
11/27/1996EP0743853A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
11/27/1996EP0743852A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
11/27/1996CN1136811A Novel(R)-5-carbamyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyranes
11/27/1996CN1136810A 5-arylisoxazol-4-yl-substituted 2-aminocarboxylic acid compounds
11/27/1996CN1136807A N-substituted azabicycloheptane derivatives their preparation and use
11/27/1996CN1136806A Prolyl endopeptidase inhibitors
11/27/1996CN1136566A Indole derivatives
11/27/1996CN1136565A Indole derivatives
11/27/1996CN1136449A Medicine for encephalatrophy and preparing method
11/27/1996CN1136436A Tablet for clearing head for cerebrorascular disease
11/27/1996CN1136432A Indole derivatives
11/27/1996CN1033391C Process for beta-carboline derivatives
11/27/1996CN1033365C Preparing method for lipides composition containing scutellaria compound
11/26/1996US5578728 Sleep disorders
11/26/1996US5578626 Pharmaceutical compositions
11/26/1996US5578624 Heteroarylpyrrolidines and their use as antipsychotics and analgesics
11/26/1996US5578617 Method and compositions for treating age related disorders
11/26/1996US5578616 Antiinflammatory agents, antiallergens, treatment for gastrointestinal and cardiovascular disorders
11/26/1996US5578612 Indole derivatives
11/26/1996US5578605 N-[(4-heteroaryl)-1-piperidinyl)alkyl]-1,2,3,4-tetrahydroquinolines and related compounds and their therapeutic utility
11/26/1996US5578603 Treatment for alzheimer*s disease, gaastrointrestinal disorders
11/26/1996US5578582 Methods of treating ischemia with C2, N6 -disubstituted adenosine derivatives
11/26/1996CA2113916C 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036632A1 Pyrrolidinyl methyl indole salt
11/21/1996WO1996036623A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996WO1996036332A1 Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
11/21/1996WO1996036328A1 A method of treatment of mania and bipolar disorder
11/21/1996CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996CA2219129A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/20/1996EP0743063A1 Use of derivatives of alpha-aminomethyl-3,4-dichlorobenzyl thioacetamide for the preparation of a medicament inhibiting the recapture of dopamine and compounds for this use
11/20/1996EP0743015A1 Health tea and method of producing same
11/20/1996EP0742716A1 Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
11/20/1996EP0742715A1 Oral liquid compositions containing paroxetine resinate
11/20/1996EP0531415B1 Method for treating alcoholism with nalmefene
11/20/1996CN1136327A Using antisense oligonucleotides to modulate nerve growth and to reverse 'beta'/A4 amyloid-induced morphology
11/20/1996CN1136316A Biologically active silicon compounds and their therapeutic and cosmetic applications
11/20/1996CN1136315A Method for preparing concentrated biologically active silicon compounds
11/20/1996CN1136312A Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136275A Heteroarylpiperidines, pyrrolidines and piprazines and their use as antipsychotics and analgetics
11/20/1996CN1136274A Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
11/20/1996CN1033330C Calcium channel blocking polypeptides from theraphosidae aphonopelma
11/20/1996CA2176654A1 Use of (.alpha.-aminomethyl-3,4-dichlorobenzyl)thioacetamide derivatives for inhibiting dopamine reuptake and new compounds for this use
11/19/1996US5576446 1-amino-2-(substituted)pyrroles and related compounds
11/19/1996US5576353 Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
1 ... 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 ... 1833